After determining that the humoral response was effective in PWH with normal CD4/CD8 ratio in response to SARS-CoV-2 vaccines, the main objective of our study was to evaluate the cellular immune response and the cell populations that were developed after receiving the complete vaccination schedule against COVID-19. The gene discussed is CD4; the disease is COVID-19.